Solid Tumor clinical trials

Explore recruiting solid tumor clinical trials.

Recruiting solid tumor studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Solid Tumor trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 1 Study of BMS-986416 with and without Nivolumab in Solid Tumors

Belgium, Netherlands

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

A study of ASP3082 in adults with advanced solid tumors

Spain, France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase I Study of INCB099280 in Combination With Ipilimumab in Participants With Selected Solid Tumors

Sweden, Norway, Slovakia

Human Pharmacology (Phase I)- Other EU CTIS Study details

PHASE 1/2, OPEN-LABEL, MULTICENTER, FIRST IN-HUMAN STUDY OF DS-3939a IN SUBJECTS WITH ADVANCED SOLID TUMORS

France, Spain, Belgium

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 1 Study of BMS-986360/CC-90001 Alone and in Combination with Chemotherapy or Nivolumab in Advanced Solid Tumors

Italy, Spain, France

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 1/2 Study of Inhaled KB707 in Patients with Advanced Solid Tumor Malignancies Affecting the Lungs

France, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Solid Tumor trials by city

Solid Tumor in Toronto Solid Tumor in Vancouver Solid Tumor in Montreal Solid Tumor in Calgary Solid Tumor in Edmonton Solid Tumor in Ottawa Solid Tumor in Winnipeg Solid Tumor in Quebec City Solid Tumor in Hamilton Solid Tumor in Kitchener Solid Tumor in London Solid Tumor in Halifax Solid Tumor in New York Solid Tumor in Los Angeles Solid Tumor in Chicago Solid Tumor in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease